脂质体布比卡因加入臂丛神经阻滞:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入21项RCT共1478例患者,评估脂质体布比卡因加入臂丛神经阻滞的术后镇痛效果。结果显示,与普通局麻药相比,脂质体布比卡因可降低术后24小时静息疼痛评分(MD=-1.04,95%CI=-1.54至-0.53,p<0.001),但证据等级为低,临床意义可能有限。
要点
- 脂质体布比卡因可显著降低臂丛阻滞后24小时静息疼痛评分,但证据等级低。
- 48小时和72小时静息疼痛评分也显著降低,且阿片类药物消耗减少。
- 恶心发生率较低,但疼痛评分改善的临床意义可能有限。
核心结论
- 低水平证据表明,脂质体布比卡因加入臂丛神经阻滞可能减轻上肢手术后的疼痛强度,但临床意义可能有限。
研究设计与样本
- 系统综述与Meta分析,纳入21项随机对照试验,共1478例患者。
- 检索PubMed、Web of Science、EMBASE、ClinicalTrials.gov和Cochrane Library至2024年6月30日。
主要发现
- 脂质体布比卡因组24小时静息疼痛评分较非脂质体局麻药组显著降低(MD=-1.04,95%CI=-1.54至-0.53,p<0.001),异质性显著(I²=81%),GRADE评级为低。
- 脂质体布比卡因组48小时和72小时静息疼痛评分也显著降低。
- 脂质体布比卡因组0-24小时、25-48小时和49-72小时阿片类药物消耗显著降低(p值<0.05)。
- 脂质体布比卡因组恶心发生率较低。
关键数值与推荐
- 主要结局为神经阻滞注射后24小时静息疼痛评分(数字评定量表,0-10分),采用随机效应模型。
- 疼痛评分的最小临床重要差异定义为平均差异1/10。
- 应用GRADE框架评估证据等级。
临床怎么用
- 对于上肢手术患者,可考虑在臂丛神经阻滞中加入脂质体布比卡因以改善术后24小时内的镇痛并减少阿片类药物消耗。
- 需注意证据等级较低且异质性显著,临床决策应结合患者具体情况。
局限性
- 证据等级为低。
- 存在显著异质性(I²=81%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adding liposomal bupivacaine to brachial plexus block may improve postoperative analgesia after upper limb surgery. OBJECTIVE: This study aimed to assess the postoperative analgesic efficacy of adding liposomal bupivacaine to brachial plexus block compared with non-liposomal local anesthetic. EVIDENCE REVIEW: A systematic literature search was conducted in PubMed, Web of Science, EMBASE, ClinicalTrials.gov, and the Cochrane Library up to June 30, 2024. Randomized controlled trials (RCTs) that evaluated the postoperative pain scores in patients who received liposomal bupivacaine via brachial plexus block were identified. The primary outcome was resting pain scores (Numerical Rating Scale, 0-10) at 24 hours after nerve block injection derived from the random effects model. A mean difference (MD) of 1/10 was considered to represent a minimal clinically important difference in pain scores. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was applied to examine the level of evidence. FINDINGS: 21 RCTs (1478 participants) were included. Liposomal bupivacaine was associated with statistically significant reduction in resting pain scores at 24 hours after nerve block injection compared with non-liposomal local anesthetic (MD=-1.04, 95% CI=-1.54 to -0.53, p<0.001, 95% prediction interval=-3.05 to 0.98). This was associated with significant heterogeneity (Q=107, p<0.001, I²=81%, tau2=1.0, 95% CI=0.42 to 2.07) and a low-GRADE rating. Liposomal bupivacaine was also associated with a statistically significant reduction in resting pain scores at 48 hours and 72 hours. Opioid consumption at 0-24 hours, 25-48 hours and 49-72 hours was lower in the liposomal bupivacaine group with statistical significance (p values <0.05). Liposomal bupivacaine was associated with a lower incidence of nausea. CONCLUSIONS: There is low-level evidence that liposomal bupivacaine in brachial plexus block may reduce pain intensity after upper limb surgery, but the clinical significance may be limited.
引用
- Shing CH, Wang F, Lam PM, et al. Addition of liposomal bupivacaine in brachial plexus blocks: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2026. PMID: 40701802. doi:10.1136/rapm-2025-106583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。